Frisso Giulia, Gelzo Monica, Procopio Elena, Sica Concetta, Lenza Maria Pia, Dello Russo Antonio, Donati Maria Alice, Salvatore Francesco, Corso Gaetano
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Napoli, Italy; CEINGE Biotecnologie Avanzate s.c.a r.l., Via Gaetano Salvatore 486, 80145 Napoli, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Napoli, Italy.
Mol Genet Metab. 2017 Aug;121(4):329-335. doi: 10.1016/j.ymgme.2017.06.013. Epub 2017 Jun 27.
Inborn defects of cholesterol biosynthesis are metabolic disorders presenting with multi-organ and tissue anomalies. An autosomal recessive defect involving the demethylating enzyme C4-methyl sterol (SC4MOL) has been reported in only 4 patients so far. In infancy, all patients were affected by microcephaly, bilateral congenital cataracts, growth delay, psoriasiform dermatitis, immune dysfunction, and intellectual disability. Herein, we describe a new case of SC4MOL deficiency in which a 19-year-old Italian male was affected by bilateral congenital cataracts, growth delay and learning disabilities, behavioral disorders and small stature, but not microcephaly. Our patient had abundant scalp dandruff, without other skin manifestations. Analysis of the blood sterol profile showed accumulation of C4-monomethyl and C4-dimethyl sterols suggesting a deficiency of the SC4MOL enzyme. Sequencing of the MSMO1 gene (also known as the "SC4MOL" gene) confirmed mutations in each allele (c.731A>G, p.Y244C, which is already known, and c.605G>A, p.G202E, which is a novel variant). His father carried c.731A>G mutation, whereas his mother carried c.605G>A. Thus, the combination of multiple skills and methodologies, in particular, blood sterol profiling and genetic analysis, led to the diagnosis of a new case of a very rare defect of cholesterol biosynthesis. Consequently, we suggest that these two analyses should be performed as soon as possible in all undiagnosed patients affected by bilateral cataracts and developmental delay.
胆固醇生物合成的先天性缺陷是一种代谢紊乱疾病,表现为多器官和组织异常。迄今为止,仅报道了4例涉及去甲基化酶C4-甲基甾醇(SC4MOL)的常染色体隐性缺陷患者。在婴儿期,所有患者均患有小头畸形、双侧先天性白内障、生长发育迟缓、银屑病样皮炎、免疫功能障碍和智力残疾。在此,我们描述了一例新的SC4MOL缺乏症病例,一名19岁的意大利男性患有双侧先天性白内障、生长发育迟缓和学习障碍、行为障碍及身材矮小,但无小头畸形。我们的患者头皮有大量头皮屑,无其他皮肤表现。血液甾醇谱分析显示C4-单甲基和C4-二甲基甾醇蓄积,提示SC4MOL酶缺乏。MSMO1基因(也称为“SC4MOL”基因)测序证实每个等位基因均有突变(已知的c.731A>G,p.Y244C,以及新的变异体c.605G>A,p.G202E)。他的父亲携带c.731A>G突变,而他的母亲携带c.605G>A。因此,多种技术和方法的结合,特别是血液甾醇谱分析和基因分析,使得诊断出一例非常罕见的胆固醇生物合成缺陷新病例。因此,我们建议对所有患有双侧白内障和发育迟缓的未确诊患者应尽快进行这两项分析。